It's no surprise that some of these firms don't pay dividends, but one once-hated company is poised to restart its payouts.
The regulator has created an accelerated path to market for the most promising drugs -- and these health giants stand to gain the most.
This sector has been back in vogue, but investors could miss out on further upside without careful stock selection.
If the rally keeps going, these picks will be winners.
Halliburton is downgraded to 'underweight,' and Eli Lilly is initiated with a 'buy.'
In a somewhat overbought market, concentrate on stocks that offer unusual value.
Fish where big fish pay big, but avoid catching that old tire.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Plus, after much ado, Softbank is oh-so-close to acquiring Sprint.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Those shackled with student loan debt are increasingly being targeted by scams and shady companies promising relief.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.